Hong Kong stocks surged | Ascentage Pharma Group-B (09606.HK) rose by more than 8% again, DB-1418 was granted fast track qualification by the FDA and approved for clinical trials in China at the same time.
According to the Wise Financial APP, Innovent Biologics-B (09606.HK) rose by over 8% again, up 7.36% to HK$329.6 as of the time of drafting, with a turnover of HK$658 million.
Latest
1 m ago
